dapoxetine has been researched along with Sex Disorders in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 31 (64.58) | 29.6817 |
| 2010's | 17 (35.42) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrianne, R | 1 |
| Cai, T; Cucchiara, V; Magno, C; Mirone, V; Palmieri, A; Sabella, F; Verze, P | 1 |
| Bull, SA; Patrick, DL; Rothman, M; Rowland, DL; Shabsigh, R; Tesfaye, F | 1 |
| Abdel-Hamid, IA | 1 |
| Gagnon, DD; Giuliano, F; Ho, KF; McNulty, P; Patrick, DL; Rothman, M | 1 |
| Hashmonay, R; Kaufman, JM; Mudumbi, RV; Rivas, D; Rosen, RC; Tesfaye, F | 1 |
| Wyllie, MG | 4 |
| Buvat, J; Giuliano, F; Rivas, DA; Rothman, M; Tesfaye, F | 1 |
| Jannini, EA | 1 |
| Balon, R | 1 |
| Porst, H | 2 |
| Bloodworth, BC; Ge, X; Koh, HL; Li, L; Low, MY | 1 |
| Hellstrom, WJ; Patel, K | 1 |
| Aquilina, J; Chang, CP; Kim, SW; McMahon, C; Park, NC; Rivas, D; Rothman, M; Tesfaye, F | 1 |
| Owen, RT | 1 |
| Dinsmore, WW; McCarty, EJ | 1 |
| Althof, SE; Aquilina, JW; Brock, GB; Bull, S; Rosen, RC; Rothman, M; Rowland, DL; Tesfaye, F | 1 |
| Althof, SE; Aquilina, JW; Bull, S; McMahon, CG; Porst, H; Rivas, DA; Sharlip, I; Tesfaye, F | 1 |
| Hoy, SM; Scott, LJ | 1 |
| Hellstrom, WJ | 2 |
| Feige, AM; Hellstrom, WJ; Pinsky, MR | 1 |
| McMahon, CG; Porst, H | 1 |
| Bramanti, P; Calabrò, RS; Casella, C; Ciurleo, R; Polimeni, G | 1 |
| Harrison-Woolrych, M | 1 |
| Cruickshank, K; Hutchinson, K; Wylie, K | 1 |
| Saitz, TR; Serefoglu, EC | 1 |
| Waldinger, MD | 2 |
| Andersson, KE; Mulhall, JP; Wyllie, MG | 1 |
| Azam, U | 1 |
| Desai, D; Dresser, MJ; Gupta, S; Lin, D; Modi, NB; Simon, M | 1 |
| Montorsi, F; Salonia, A | 1 |
| Althof, SE; Hellstrom, WJ; Kell, S; Miloslavsky, M; Pryor, JL; Rosen, RC; Shabsigh, R; Steidle, C | 1 |
| Salokangas, RK | 1 |
| Olivier, B; Schweitzer, DH; Waldinger, MD | 1 |
| Payne, RE; Sadovsky, R | 1 |
| Chen, B; Guo, JH | 1 |
| Olivier, B; Schweitzer, DH; Waldinger, MD; Zwinderman, AH | 1 |
| Giuliano, F | 1 |
| Cassels, A | 1 |
| Schweitzer, DH; Waldinger, MD | 2 |
| Goldstein, I | 1 |
18 review(s) available for dapoxetine and Sex Disorders
| Article | Year |
|---|---|
Pharmacologic treatment of rapid ejaculation: levels of evidence-based review.
Topics: Antidepressive Agents, Tricyclic; Benzylamines; Ejaculation; Humans; Male; Naphthalenes; Phosphodiesterase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sexual Dysfunction, Physiological | 2006 |
[Premature ejaculation].
Topics: Anesthetics, Local; Benzylamines; Ejaculation; Humans; Lidocaine; Male; Marital Therapy; Naphthalenes; Prilocaine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2009 |
Central regulation of ejaculation and the therapeutic role of serotonergic agents in premature ejaculation.
Topics: Antidepressive Agents; Benzylamines; Brain; Clinical Trials as Topic; Ejaculation; Humans; Male; Naphthalenes; Neurotransmitter Agents; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Sexual Dysfunction, Physiological | 2009 |
Premature ejaculation: treatment update.
Topics: Administration, Oral; Administration, Topical; Anesthetics, Combined; Anesthetics, Local; Benzylamines; Ejaculation; Enzyme Inhibitors; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Naphthalenes; Phosphodiesterase 5 Inhibitors; Prilocaine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2010 |
Dapoxetine: in premature ejaculation.
Topics: Adult; Benzylamines; Coitus; Ejaculation; Female; Humans; Male; Middle Aged; Naphthalenes; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Young Adult | 2010 |
Available and future therapies for premature ejaculation.
Topics: Animals; Benzylamines; Drug Therapy, Combination; Drugs, Investigational; Ejaculation; Evidence-Based Medicine; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Naphthalenes; Prilocaine; Quality of Life; Sexual Dysfunction, Physiological; Treatment Outcome | 2010 |
Update on treatments for premature ejaculation.
Topics: Analgesics, Opioid; Anesthetics, Local; Benzylamines; Ejaculation; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Naphthalenes; Phosphodiesterase 5 Inhibitors; Prilocaine; Serotonin Agents; Sexual Dysfunction, Physiological; Tramadol | 2011 |
Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Benzylamines; Clomipramine; Drug Therapy, Combination; Ejaculation; Humans; Male; Naphthalenes; Narcotics; Phosphodiesterase 5 Inhibitors; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Tramadol; Treatment Outcome | 2011 |
Neurogenic ejaculatory disorders: focus on current and future treatments.
Topics: Benzylamines; Ejaculation; Humans; Male; Naphthalenes; Nervous System Diseases; Premature Ejaculation; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological | 2011 |
An overview of pharmacotherapy in premature ejaculation.
Topics: Anesthetics, Local; Antidepressive Agents, Tricyclic; Behavior Therapy; Benzylamines; Counseling; Ejaculation; Humans; Male; Naphthalenes; Phosphodiesterase 5 Inhibitors; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological | 2011 |
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
Topics: Benzylamines; Ejaculation; Humans; Male; Naphthalenes; Patient Satisfaction; Randomized Controlled Trials as Topic; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Treatment Outcome | 2012 |
New insights on premature ejaculation: a review of definition, classification, prevalence and treatment.
Topics: Animals; Benzylamines; Coitus; Humans; Lidocaine; Male; Naphthalenes; Piperazines; Premature Ejaculation; Prevalence; Prilocaine; Purines; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones | 2012 |
Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment.
Topics: Animals; Benzylamines; Ejaculation; Humans; Male; Naphthalenes; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Dysfunction, Physiological; Synaptic Transmission | 2005 |
Late-stage clinical development in lower urogenital targets: sexual dysfunction.
Topics: Alprostadil; Androgens; Benzylamines; Clinical Trials as Topic; Dopamine Agonists; Ejaculation; Erectile Dysfunction; Female; Humans; Male; Naphthalenes; Phosphodiesterase Inhibitors; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents | 2006 |
Emerging drugs for premature ejaculation.
Topics: Administration, Oral; Animals; Benzylamines; Central Nervous System; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ejaculation; Half-Life; Humans; Male; Naphthalenes; Paroxetine; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sexual Dysfunction, Physiological | 2006 |
Identifying and treating premature ejaculation: importance of the sexual history.
Topics: Administration, Topical; Anesthetics; Antidepressive Agents, Tricyclic; Benzylamines; Diagnosis, Differential; Ejaculation; Humans; Male; Medical History Taking; Naphthalenes; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Counseling; Sexual Behavior; Sexual Dysfunction, Physiological | 2007 |
[Update of pharmacotherapy for premature ejaculation].
Topics: Benzylamines; Humans; Male; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2007 |
Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
Topics: Animals; Benzylamines; Controlled Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Industry; Ejaculation; Evidence-Based Medicine; Humans; Male; Meta-Analysis as Topic; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2008 |
8 trial(s) available for dapoxetine and Sex Disorders
| Article | Year |
|---|---|
Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
Topics: Benzylamines; Coitus; Double-Blind Method; Ejaculation; Humans; Male; Naphthalenes; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sexual Dysfunction, Physiological; Treatment Outcome | 2008 |
The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice.
Topics: Adult; Benzylamines; Coitus; Ejaculation; Humans; Interpersonal Relations; Male; Naphthalenes; Patient Satisfaction; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sexual Dysfunction, Physiological; Treatment Outcome | 2009 |
Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.
Topics: Adult; Benzylamines; Coitus; Double-Blind Method; Ejaculation; Humans; Interpersonal Relations; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sexual Dysfunction, Physiological; Treatment Outcome; Young Adult | 2009 |
Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.
Topics: Adult; Benzylamines; Double-Blind Method; Ejaculation; Humans; Male; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2009 |
Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
Topics: Adult; Benzylamines; Dose-Response Relationship, Drug; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Treatment Outcome | 2010 |
Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculation.
Topics: Adult; Benzylamines; Dose-Response Relationship, Drug; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Psychometrics; Quality of Life; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Surveys and Questionnaires | 2010 |
Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials.
Topics: Adult; Benzylamines; Dose-Response Relationship, Drug; Double-Blind Method; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2010 |
Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation.
Topics: Administration, Oral; Adolescent; Adult; Benzylamines; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Ejaculation; Humans; Male; Middle Aged; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2006 |
22 other study(ies) available for dapoxetine and Sex Disorders
| Article | Year |
|---|---|
[Dapoxetine (Priligy): on demand treatment of premature ejaculation].
Topics: Benzylamines; Clinical Trials as Topic; Ejaculation; Humans; Male; Naphthalenes; Serotonin Antagonists; Sexual Dysfunction, Physiological | 2013 |
Comparison of Treatment Emergent Adverse Events in Men With Premature Ejaculation Treated With Dapoxetine and Alternate Oral Treatments: Results From a Large Multinational Observational Trial.
Topics: Administration, Oral; Adult; Aged; Benzylamines; Ejaculation; Humans; Male; Middle Aged; Mood Disorders; Naphthalenes; Outcome Assessment, Health Care; Penile Erection; Premature Ejaculation; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunction, Physiological; Treatment Outcome | 2016 |
MMIX: annus festine lente?
Topics: Benzylamines; Humans; Male; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Technology, Pharmaceutical | 2009 |
Editorial comment on: Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.
Topics: Benzylamines; Clinical Trials, Phase III as Topic; Double-Blind Method; Ejaculation; Humans; Male; Multicenter Studies as Topic; Naphthalenes; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2009 |
Dapoxetine debate and conflict of interest.
Topics: Benzylamines; Conflict of Interest; Controlled Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Industry; Humans; Male; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2009 |
Isolation and structural elucidation of dapoxetine as an adulterant in a health supplement used for sexual performance enhancement.
Topics: Benzylamines; Chemistry, Pharmaceutical; Dietary Supplements; Drug Contamination; Erectile Dysfunction; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry; Temperature | 2009 |
Dapoxetine: a novel treatment for premature ejaculation.
Topics: Benzylamines; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Interactions; Ejaculation; Humans; Male; Naphthalenes; Patient Compliance; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Treatment Outcome | 2009 |
The dapoxetine paradox.
Topics: Benzylamines; Ejaculation; Humans; Male; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2010 |
Dapoxetine for premature ejaculation.
Topics: Animals; Benzylamines; Ejaculation; Humans; Male; Naphthalenes; Protein Isoforms; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2011 |
Patient reporting encouraged during monitoring of dapoxetine in New Zealand.
Topics: Adverse Drug Reaction Reporting Systems; Benzylamines; Drug Monitoring; Ejaculation; Humans; Male; Naphthalenes; New Zealand; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Surveys and Questionnaires | 2011 |
The brain leads the way.
Topics: Benzylamines; Drug Industry; Duloxetine Hydrochloride; Ejaculation; Forecasting; Humans; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Thiophenes; Urinary Incontinence, Stress; Wit and Humor as Topic | 2004 |
Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation.
Topics: Benzylamines; Dose-Response Relationship, Drug; Ejaculation; Humans; Male; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2006 |
Just hold on a minute (or should it be two?).
Topics: Benzylamines; Drug Approval; Ejaculation; Humans; Male; Naphthalenes; Sexual Dysfunction, Physiological | 2006 |
Medical therapy for premature ejaculation.
Topics: Animals; Benzylamines; Ejaculation; Humans; Male; Naphthalenes; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2006 |
Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.
Topics: Adult; Aged; Benzylamines; Double-Blind Method; Ejaculation; Female; Humans; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Time Factors; Treatment Outcome | 2006 |
Dapoxetine for treatment of premature ejaculation.
Topics: Benzylamines; Bipolar Disorder; Ejaculation; Humans; Male; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2006 |
Dapoxetine treatment of premature ejaculation.
Topics: Benzylamines; Dose-Response Relationship, Drug; Ejaculation; Humans; Male; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2006 |
The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observation study in a consecutive group of Dutch men.
Topics: Adult; Benzylamines; Clomipramine; Cohort Studies; Coitus; Dose-Response Relationship, Drug; Ejaculation; Humans; Male; Middle Aged; Naphthalenes; Netherlands; Paroxetine; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Tramadol; Treatment Outcome | 2007 |
Interview with Dr François Giuliano (by Christine McKillop). New avenues in the pharmacological treatment of premature ejaculation.
Topics: Anesthetics, Local; Benzylamines; Ejaculation; Humans; Male; Naphthalenes; Pilocarpine; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological | 2007 |
W is for Wilbert's wee willy (which tends to go off prematurely).
Topics: Benzylamines; Drug Approval; Drug Industry; Ejaculation; Female; Humans; Male; Marketing of Health Services; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2007 |
Re: François Giuliano, Donald L. Patrick, Hartmut Porst, et Al. for the 3004 study group. Premature ejaculation: results from a five-country European observational study. Eur urol 2008;53:1048-57.
Topics: Benzylamines; Ejaculation; Europe; Humans; Male; Naphthalenes; Sexual Dysfunction, Physiological; Time Factors | 2008 |
Regarding Waldinger and Schweitzer's "premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case".
Topics: Animals; Benzylamines; Drug Evaluation, Preclinical; Drug Industry; Ejaculation; Evidence-Based Medicine; Humans; Male; Naphthalenes; Organizational Objectives; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2008 |